DOH Health Advisory: Recommendations to Resume Use of the Janssen/Johnson & Johnson COVID-19 Vaccine

DOH has issued recommendations for resuming use of the Janssen/Johnson & Johnson COVID-19 vaccine. The document outlines considerations for the use of the vaccine in certain populations and warns of possible adverse effects to monitor and report.
The advisory should be distributed to all personnel conducting medical screening and evaluation, vaccine administration, pharmacists, specialists, and all primary care providers.

DOH COVID-19 Policy for Use of Predrawn Vaccine for Homebound, Nursing Homes and Adult Care Facilities

CDC has permitted predrawing of COVID-19 vaccines subject to certain conditions. The new DOH policy requires that healthcare entities that have determined it appropriate to use predrawn syringes should develop policies and protocols to avoid compromising and wasting vaccine and to maintain the cold chain, consistent with the recommendations detailed herein. This document applies only to providers vaccinating homebound individuals, and vaccination for individuals in nursing homes and adult care facilities.

For more information, please contact Andrew Jewett, Director, Hospital Preparedness Program at